Matthew J During
Matthew J During
Emrys Bio
Verified email at
Cited by
Cited by
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …
M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...
Diabetes care 32 (1), 84-90, 2009
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
MG Kaplitt, P Leone, RJ Samulski, X Xiao, DW Pfaff, KL O'Malley, ...
Nature genetics 8 (2), 148-154, 1994
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
MG Kaplitt, A Feigin, C Tang, HL Fitzsimons, P Mattis, PA Lawlor, ...
The Lancet 369 (9579), 2097-2105, 2007
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
MJ During, DD Spencer
The lancet 341 (8861), 1607-1610, 1993
VEGF links hippocampal activity with neurogenesis, learning and memory
L Cao, X Jiao, DS Zuzga, Y Liu, DM Fong, D Young, MJ During
Nature genetics 36 (8), 827-835, 2004
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
D Young, PA Lawlor, P Leone, M Dragunow, MJ During
Nature medicine 5 (4), 448-453, 1999
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During, L Cao, DS Zuzga, JS Francis, HL Fitzsimons, X Jiao, RJ Bland, ...
Nature medicine 9 (9), 1173-1179, 2003
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
RE MacLaren, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
The Lancet 383 (9923), 1129-1137, 2014
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
K Monory, F Massa, M Egertová, M Eder, H Blaudzun, R Westenbroek, ...
Neuron 51 (4), 455-466, 2006
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
PA LeWitt, AR Rezai, MA Leehey, SG Ojemann, AW Flaherty, ...
The Lancet Neurology 10 (4), 309-319, 2011
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach
W Lu, Y Shi, AC Jackson, K Bjorgan, MJ During, R Sprengel, PH Seeburg, ...
Neuron 62 (2), 254-268, 2009
Adenosine: a potential mediator of seizure arrest and postictal refractoriness
MJ During, DD Spencer
Annals of neurology 32 (5), 618-624, 1992
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase
MJ During, JR Naegele, KL O'Malley, AI Geller
Science 266 (5189), 1399-1403, 1994
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release
WP Borg, RS Sherwin, MJ During, MA Borg, GI Shulman
Diabetes 44 (2), 180-184, 1995
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
H Johnen, S Lin, T Kuffner, DA Brown, VWW Tsai, AR Bauskin, L Wu, ...
Nature medicine 13 (11), 1333-1340, 2007
Hippocampal GABA transporter function in temporal-lobe epilepsy
MJ During, KM Ryder, DD Spencer
Nature 376 (6536), 174-177, 1995
Subthalamic GAD gene therapy in a Parkinson's disease rat model
J Luo, MG Kaplitt, HL Fitzsimons, DS Zuzga, Y Liu, ML Oshinsky, ...
Science 298 (5592), 425-429, 2002
White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis
L Cao, EY Choi, X Liu, A Martin, C Wang, X Xu, MJ During
Cell metabolism 14 (3), 324-338, 2011
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
MJ During, CW Symes, PA Lawlor, J Lin, J Dunning, HL Fitzsimons, ...
Science 287 (5457), 1453-1460, 2000
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
WP Borg, MJ During, RS Sherwin, MA Borg, ML Brines, GI Shulman
The Journal of clinical investigation 93 (4), 1677-1682, 1994
The system can't perform the operation now. Try again later.
Articles 1–20